The DOI matches its Crossref record.
Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism.
Open accessAbstract
Venous thromboembolism is a serious, potentially lethal health problem affecting 1 per 1,000 people annually (1-3).Major surgery, fractures, complicated pregnancy, the use of oral con- traceptives, and immobilization increase the risk of thrombosis.In addition, thrombosis is often familial, suggesting that genetic risk factors are involved (3-6).Until recently, the major genetic defects known to predispose for thrombosis were deficiencies of antithrombin III, protein C, and protein S. Together these did not account for more than 5-10% of the cases (3-5, 7).In the last year, hereditary activated protein C (APC)' resistance, has been identified as a basis for a majority of cases of familial thrombosis (8-13).In contrast to other genetic de- fects associated with thrombosis, APC resistance is highly prev- alent in the general population (8, 10).It afflicts affected individuals with a life-long increased risk of thrombosis.APC resistance, its molecular basis, and a short description of the protein C anticoagulant system will be presented.Balance between pro-and anticoagulant forces A number of plasma proteins function in harmony with cellular components to provide efficient and localized hemostasis (14, 15).Proteolytic events arranged in a cascade fashion lead to the explosive, but yet controlled formation of thrombin.Thrombin generated at sites of vascular injury activates factors V and VII (to Va and Villa) in a positive feedback reaction, activates and aggregates platelets and converts fibrinogen into insoluble fibrin (Fig. 1).Factors Va and Villa bind to negatively charged phos- pholipids exposed on activated platelets and serve as receptor sites for the proteolytic enzymes, factors IXa and Xa, respec- tively ( 15, 16).In contrast, at sites of intact vasculature, binding of thrombin to the endothelial membrane protein thrombo- modulin converts thrombin from a procoagulant into an antico- agulant protease, which activates protein C ( 17-19).APC inactivates the membrane bound factors Va and VIIIa by limited proteolysis in a reaction which is potentiated by a cofactor protein designated protein S. APC is highly specific in its action.It cleaves and inactivates cell surface bound factors Va and VIlla, but has no effect on circulating factors V and VI.Pro- and anticoagulant mechanisms are under physiological condi-
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Branch Retinal Vein Occlusion: Pathogenesis, Visual Prognosis, and Treatment Modalities
Rehak, J., & Rehak, M. (2008) · Current Eye Research · doi:10.1080/02713680701851902 · Cited by 429
Esmon, C. T. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.10.7615164 · Cited by 377
Rosendaal, F. R., Siscovick, D. S., Schwartz, S. M., Beverly, R. K., Psaty, B. M., Longstreth, W. T., Raghunathan, T. E., Koepsell, T. D., & Reitsma, P. H. (1997) · Blood · doi:10.1182/blood.v89.8.2817 · Cited by 372
Immunology of the antiphospholipid antibody syndrome
Roubey, R. A. S. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390903 · Cited by 302
Laszik, Z., Mitro, A., Taylor, F. B., Ferrell, G., & Esmon, C. T. (1997) · Circulation · doi:10.1161/01.cir.96.10.3633 · Cited by 291
Metadata
- Authors
- Dahlbäck, B.
- Venue
- Journal of Clinical Investigation
- Published
- 1994-09-01
- Volume
- 94
- Issue
- 3
- Pages
- 923-927
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2036117417
- Cited by
- 164
- References
- 0
- FWCI
- 14.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism. https://app.cochat.ai/papers/10.1172/jci117458
- The paper
- Dahlbäck, B. (1994). Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism. Journal of Clinical Investigation. https://doi.org/10.1172/jci117458
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.